U.S. Pharmaceutical Sales - Q2 2011

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q2 2011 by Sales

Rank Drug Sales ($000)
1 Lipitor
Pfizer Inc
2.11% Stats
2 Plavix
Bristol-Myers Squibb Company
2.61% Stats
3 Nexium
AstraZeneca Pharmaceuticals, LP
-1.65% Stats
4 Abilify
Otsuka Pharmaceutical Co., Ltd
2.79% Stats
5 (3) Singulair
Merck & Co., Inc.
11.74% Stats
6 (1) Advair Diskus
GlaxoSmithKline
-2.39% Stats
7 (1) Seroquel
AstraZeneca Pharmaceuticals, LP
-0.33% Stats
8 (1) Crestor
AstraZeneca Pharmaceuticals, LP
2.32% Stats
9 Actos
Takeda Pharmaceuticals U.S.A., Inc
-13.56% Stats
10 (2) Remicade
Centocor Ortho Biotech, Inc
7.61% Stats
11 (2) Zyprexa
Eli Lilly and Company
7.93% Stats
12 (2) Cymbalta
Eli Lilly and Company
5.03% Stats
13 (2) Enbrel
Amgen Inc.
3.77% Stats
14 Humira
AbbVie, Inc.
6.32% Stats
15 Neulasta
Amgen Inc.
4.04% Stats
16 (4) Rituxan
Genentech, Inc (member of Roche group)
7.26% Stats
17 OxyContin
2.82% Stats
18 Lexapro
Forest Pharmaceuticals, Inc
3.15% Stats
19 (3) Copaxone
Teva Pharmaceuticals
0.29% Stats
20 (1) Epogen
Amgen Inc.
3.32% Stats
21 Avastin
Genentech, Inc (member of Roche group)
-1.29% Stats
22 Atripla
Gilead Sciences, Inc.
6.31% Stats
23 Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
3.82% Stats
24 (3) Januvia
Merck & Co., Inc.
8.81% Stats
25 (1) Diovan
Novartis Corporation
5.84% Stats
26 (2) Lantus
Sanofi (formerly Sanofi Aventis)
-3.90% Stats
27 (1) Truvada
Gilead Sciences, Inc.
8.66% Stats
28 (1) Celebrex
Pfizer Inc
1.25% Stats
29 (1) Lyrica
Pfizer Inc
0.72% Stats
30 (3) Lucentis
Genentech, Inc (member of Roche group)
0.95% Stats
31 (3) Diovan HCT
Novartis Corporation
4.51% Stats
32 (4) Herceptin
Genentech, Inc (member of Roche group)
3.62% Stats
33 (4) Avonex
Biogen Idec
2.45% Stats
34 (5) Namenda
Forest Pharmaceuticals, Inc
5.72% Stats
35 (3) OneTouch
2.37% Stats
36 (5) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
7.80% Stats
37 (3) Gleevec
Novartis Corporation
1.64% Stats
38 (7) venlafaxine
Generic
-21.22% Stats
39 (8) enoxaparin
Generic
8.08% Stats
40 (2) Zetia
Merck & Co., Inc.
1.10% Stats
41 (7) Procrit
Janssen Pharmaceuticals, Inc
7.04% Stats
42 (1) TriCor
Abbott Laboratories
-0.60% Stats
43 (1) Geodon
Pfizer Inc
-0.33% Stats
44 (5) Vyvanse
Shire US Inc
-1.39% Stats
45 (5) Niaspan
Abbott Laboratories
0.54% Stats
46 (6) Lidoderm
Endo Pharmaceuticals
1.37% Stats
47 (6) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
3.08% Stats
48 (3) Aranesp
Amgen Inc.
-1.03% Stats
49 (7) AndroGel
AbbVie, Inc.
6.52% Stats
50 (20) Provigil
Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd)
17.28% Stats
51 (4) Nasonex
Merck & Co., Inc.
0.96% Stats
52 (27) Levaquin
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
-42.70% Stats
53 (8) Lovenox
Sanofi (formerly Sanofi Aventis)
-17.22% Stats
54 Vytorin
Merck & Co., Inc.
-4.04% Stats
55 () Eloxatin
Sanofi (formerly Sanofi Aventis)
Stats
56 (24) Concerta
-37.94% Stats
57 (1) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
-1.62% Stats
58 (7) Lovaza
GlaxoSmithKline
3.98% Stats
59 (2) Rebif
0.25% Stats
60 (2) Symbicort
AstraZeneca Pharmaceuticals, LP
0.64% Stats
61 (5) Novolog
Novo Nordisk, Inc.
3.16% Stats
62 (1) Adderall XR
Shire US Inc
1.34% Stats
63 (4) Alimta
Eli Lilly and Company
3.76% Stats
64 (5) Viagra
Pfizer Inc
-2.00% Stats
65 (3) Seroquel XR
AstraZeneca Pharmaceuticals, LP
2.86% Stats
66 (9) amphetamine/dextroamphetamine
Generic
7.09% Stats
67 (5) Humalog
Eli Lilly and Company
4.83% Stats
68 (1) metoprolol
Generic
0.96% Stats
69 (5) Flovent HFA
GlaxoSmithKline
-3.77% Stats
70 (4) Neupogen
Amgen Inc.
2.51% Stats
71 (5) Reyataz
Bristol-Myers Squibb Company
1.96% Stats
72 (1) Aciphex
Eisai Corporation
-4.54% Stats
73 (5) fentanyl
Generic
-0.62% Stats
74 (1) ProAir HFA
Teva Pharmaceuticals
-6.71% Stats
75 (5) Levemir
Novo Nordisk, Inc.
-0.11% Stats
76 (3) Lunesta
Sunovion Pharmaceuticals Inc.
-2.53% Stats
77 () Varivax
Merck & Co., Inc.
Stats
78 (11) Janumet
Merck & Co., Inc.
8.93% Stats
79 (33) donepezil
Generic
-39.00% Stats
80 (1) Cialis
Eli Lilly and Company
0.51% Stats
81 (16) bupropion
Generic
8.02% Stats
82 () docetaxel
Generic
Stats
83 () methylphenidate
Generic
Stats
84 (16) Isentress
Merck & Co., Inc.
7.95% Stats
85 (2) valacyclovir
Generic
-0.78% Stats
86 (7) NovoLog FlexPen
Novo Nordisk, Inc.
3.71% Stats
87 (4) Evista
Eli Lilly and Company
2.43% Stats
88 (2) Restasis
Allergan, Inc
1.43% Stats
89 (4) Betaseron
Bayer Healthcare Pharmaceuticals
-2.17% Stats
90 (2) Solodyn
Medicis Pharmaceutical Corporation
1.84% Stats
91 (9) Zyvox
Pfizer Inc
-4.59% Stats
92 (2) Benicar
Daiichi Sankyo
-1.37% Stats
93 (2) Erbitux
Bristol-Myers Squibb Company
-0.89% Stats
94 () Velcade
Takeda Pharmaceuticals U.S.A., Inc
Stats
95 (18) budesonide
Generic
-24.47% Stats
96 (8) Zometa
-6.47% Stats
97 () VESIcare
Astellas Pharma US
Stats
98 () acetaminophen/hydrocodone
Generic
Stats
99 () Synthroid
Abbott Laboratories
Stats
100 (2) Detrol LA
Pfizer Inc
-7.49% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web2)